Literature DB >> 15095817

Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs.

Gwen Crevensten1, Andrew J L Walsh, Dheera Ananthakrishnan, Paul Page, George M Wahba, Jeffrey C Lotz, Sigurd Berven.   

Abstract

This study explores the use of mesenchymal stem cells (MSCs) for intervertebral disc regeneration. We used an in vivo model to investigate the feasibility of exogenous cell delivery, retention, and survival in the pressurized disc space. MSC injection into rat coccygeal discs was performed using 15% hyaluronan gel as a carrier. Injections of gel with or without MSCs were performed. Immediately after injection, fluorescently labeled stem cells were visible on sections of cell-injected discs. Seven and 14 days after injection, stem cells were still present within the disc, but their numbers were significantly decreased. At 28 days, a return to the initial number of injected cells was observed, and viability was 100%. A trend of increased disc height compared to blank gel suggests an increase in matrix synthesis. The results indicate that MSCs can maintain viability and proliferate within the rat intervertebral disc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095817     DOI: 10.1023/b:abme.0000017545.84833.7c

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  94 in total

1.  Structured coculture of mesenchymal stem cells and disc cells enhances differentiation and proliferation.

Authors:  Aliza A Allon; Kristin Butcher; Richard A Schneider; Jeffrey C Lotz
Journal:  Cells Tissues Organs       Date:  2012-03-01       Impact factor: 2.481

Review 2.  What is the preclinical evidence on platelet rich plasma and intervertebral disc degeneration?

Authors:  Matteo Formica; Luca Cavagnaro; Carlo Formica; Milena Mastrogiacomo; Marco Basso; Alberto Di Martino
Journal:  Eur Spine J       Date:  2015-08-14       Impact factor: 3.134

3.  In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector.

Authors:  D Nicole Worsham; Todd Schuesler; Christof von Kalle; Dao Pan
Journal:  Mol Ther       Date:  2006-08-07       Impact factor: 11.454

Review 4.  Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction.

Authors:  Victor Y L Leung; Danny Chan; Kenneth M C Cheung
Journal:  Eur Spine J       Date:  2006-07-15       Impact factor: 3.134

5.  Three-dimensional morphology of the pericellular matrix of intervertebral disc cells in the rat.

Authors:  Li Cao; Farshid Guilak; Lori A Setton
Journal:  J Anat       Date:  2007-08-02       Impact factor: 2.610

6.  Photocrosslinkable laminin-functionalized polyethylene glycol hydrogel for intervertebral disc regeneration.

Authors:  Aubrey T Francisco; Priscilla Y Hwang; Claire G Jeong; Liufang Jing; Jun Chen; Lori A Setton
Journal:  Acta Biomater       Date:  2013-11-25       Impact factor: 8.947

Review 7.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

8.  Extracellular matrix production by nucleus pulposus and bone marrow stem cells in response to altered oxygen and glucose microenvironments.

Authors:  Syeda M Naqvi; Conor T Buckley
Journal:  J Anat       Date:  2015-04-25       Impact factor: 2.610

Review 9.  Mechanical design criteria for intervertebral disc tissue engineering.

Authors:  Nandan L Nerurkar; Dawn M Elliott; Robert L Mauck
Journal:  J Biomech       Date:  2010-01-18       Impact factor: 2.712

10.  Disc cell therapy with bone-marrow-derived autologous mesenchymal stromal cells in a large porcine disc degeneration model.

Authors:  G W Omlor; S Lorenz; A G Nerlich; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2018-08-23       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.